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Which	tests	are	the	most		
useful	for	diagnosing	PID?
z	Evidence	summary
Our search for articles that examined 
patient- and primary care–oriented PID 
diagnostic tests resulted in 2 systematic 
reviews, no randomized controlled trials, 
4 data analyses, and 5 cohort studies, all 
of which were fair- to good-quality.
Systematic	reviews		
don’t	show	consistent	results
One systematic review of 12 fair- to 
good-quality studies, based in Europe 
and the US, included urban populations 
treated in Ob/Gyn departments, emer-
gency rooms, and sexually transmitted 
c o N T I N u e D
		
No single test has adequate sensitivity 
and specificity to reliably identify pelvic 
inflammatory disease (PID) and thus help  
to spare women serious sequelae, including 
infertility (strength of recommendation [sor]: 
B, based on systematic reviews of cohort 
studies and individual cohort studies). 
a large multisite us study found that 
using adnexal tenderness as a minimum 
clinical criterion raises the sensitivity of the 
centers for Disease control and Prevention 
(cDc) criteria from 83% to 95%.1 however, 
even the modified 2002 cDc criteria fail to 
identify women with subclinical PID who  
are at roughly equivalent risk for PID 
sequelae as those with acute symptomatic 
disease2 (sor: B, based on individual 
cohort studies).
it’s prudent to treat when there  
is a clinical diagnosis of PiD
Women presenting with acute pelvic 
pain need thorough evaluation to rule out 
ectopic pregnancy, cystitis, pyelonephritis, 
appendicitis, and ovarian torsion. In my 
experience, a likely history of a sexually 
transmitted disease along with adnexal 
pain or cervical motion tenderness 
on examination is the most helpful in 
diagnosing PID. 
an elevated white blood cell (WBc) 
count, erythrocyte sedimentation rate (esr), 
or c-reactive protein (crP) may help sup-
port the diagnosis. PID often becomes a 
diagnosis of exclusion if human chorionic 
gonadotropin (hcG), urine evaluation, and 
pelvic ultrasound are negative. 
While PID is sometimes a frustrating 
diagnosis to make and is often viewed 
as a “wastebasket” diagnosis, empiric 
treatment may be beneficial. While we 
would love to know whether treating 
pending culture results reduces the risk 
of sepsis and infertility, it seems prudent 
to treat when we have made a clinical 
diagnosis of PID.
Kismet T. roberts, mD
university of Nebraska medical center;  
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evidence-based answer
clinical commentary
One study  
found that the  
combination of 
symptoms for <1 
week, adnexal 
tenderness, and 
elevated WBC was 
the most sensitive 
set of predictors
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disease clinics. This review supports a 
thorough evaluation when more severe 
disease is suspected and the use of sen-
sitive diagnostic tests for suspected mild 
disease—eg, CRP (74%–93% sensitivity) 
and ESR (64%–81% sensitivity for value 
>20 or 15 mm/h).3 
Another systematic review of 19 fair- 
to good-quality cohort studies found a 
sensitivity of only 64% for laparoscopy, 
50% to 87% for endometrial biopsy, and 
up to 80% for microbiological tests. Re-
sults were not consistent for the reported 
sensitivity of WBC, ESR, or CRP.4
Multivariate	analyses	of	Swedish	
data	come	to	different	conclusions
We identified no randomized controlled 
trials that addressed the diagnosis of PID. 
Two multivariate analyses of the same 
Swedish data from the 1960s came to 
different conclusions. 
The Lund analysis includes data col-
lected between 1960 and 1969 at Lund 
University Hospital in Sweden on women 
with suspected PID, with about 625 cases 
included for these analyses. Simms et al5 
found insufficient evidence from these 
data for any existing diagnostic criteria.
Looking at the same data, Hagdu et al 
proposed the use of a clinical criteria mod-
el including low abdominal pain and 2 or 
more of the following other criteria: vagi-
nal discharge, temperature greater than 
38°C, vomiting, irregular menses, urologic 
or proctitis symptoms, pelvic tenderness, 
adnexal mass or swelling, and ESR ≥15.6 
This model had a reported sensitivity of 
87%, specificity of 52.5%, and false-posi-
tive and false-negative rates of 21.2% and 
33.3%, respectively.
Looking	at	adnexal	tenderness	
aids	sensitivity	of	other	tests
Cross-sectional analysis of a multisite US 
randomized treatment trial supported 
using adnexal tenderness as a minimum 
clinical criterion to increase sensitivity.1 
Further analysis of that trial suggests 
that some asymptomatic women are at 
equivalent risk of developing sequelae 
compared with symptomatic women di-
agnosed with PID. Those asymptomatic 
women who met diagnostic criteria with 
a positive endometrial biopsy were more 
likely to have pelvic tenderness than 
asymptomatic women who were not 
diagnosed.2
Symptoms	>1	week		
and	elevated	WBC	also	helpful
Two small, fair-quality cohort studies 
(N=61 and 176, respectively) investigated 
the use of clinical diagnostic criteria for 
PID. The smaller study compared clini-
cal criteria to several reference standards 
(laparoscopy, histology, microbiological 
markers, and transvaginal ultrasound) 
and found clinical criteria, specifically ad-
nexal tenderness, most sensitive (87%), 
and laparoscopy most specific (100%).7 
In the second study, the authors 
evaluated 176 consecutive admissions 
for clinically diagnosed PID, 76% of 
which were laparoscopically confirmed. 
Reviewing clinical indicators, they found 
that a combination of adnexal tender-
ness, symptoms for <1 week, and el-
evated WBC was the most sensitive set 
of predictors (sensitivity 86.6%, specific-
ity 45.7%) with positive predictive value 
of 0.84 and negative predictive value of 
0.52.8
Useful	lab	indicators:	C-reactive	
protein,	serum	CA-125
Three small cohort studies (N=50–152) 
of fair-quality evaluated various labora-
tory indicators in the diagnosis of PID. 
Each used a different reference standard: 
clinical criteria, laparoscopy, and endo-
metrial biopsy, respectively. 
One study found CRP >10 to be 
93% sensitive and 83% specific in a co-
hort of women admitted to the emergency 
department with an acute gynecologi-
cal disorder.9 This population had a high 
baseline incidence of PID, pregnancy, and 
intrauterine device use. 
A study of serum CA-125 levels 
showed a predictive value of 97% for val-
ues >16 U/mL in diagnosing salpingitis. 
One review  
supports the use 
of C-reactive  
protein and ESR 
when you suspect 
mild PID
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This test might therefore be useful in con-
firming peritoneal involvement when PID 
is suspected clinically.10 
Another study developed a model us-
ing vaginal WBC (the single most sensitive 
factor at 78%), serum WBC (the single 
most specific factor at 88%), CRP, and 
ESR. The model was 100% sensitive if the 
diagnosis only required 1 positive test, al-
though the specificity was only 18%. The 
positive predictive value was 65%. If all 
4 were positive, specificity was 95%, with 
29% sensitivity, a positive predictive value 
of 90%, and a negative predictive value of 
47%. Prevalence was 60% in the group 
studied.11
Recommendations	from	others
The CDC recommends empiric treat-
ment of women with lower abdominal 
or pelvic pain who are at risk for sexu-
ally transmitted diseases with uterine, ad-
nexal, or cervical motion tenderness and 
no other identifiable cause.12 
Clinical Evidence found no RCTs that 
compared empiric treatment of suspected 
PID with waiting for microbiological test 
results for guidance.13 
The Agency for Healthcare Research 
and Quality recommends requiring the 
presence of lower abdominal, adnexal and 
cervical tenderness, without alternative di-
agnosis, for the diagnosis of PID. Tempera-
ture >101°F, cervical or vaginal discharge, 
elevated ESR, and positive gonococcal or 
chlamydia cultures all increase specificity 
of diagnosis.14 
The United Kingdom’s national 
guideline recommends maintaining a 
low threshold for empirical treatment, 
citing a lack of definitive diagnostic cri-
teria and potential for sequelae, but does 
recommend testing for gonorrhea and 
chlamydia.15 n
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Adnexal, lower 
abdominal,  
and cervical  
tenderness,  
without alternative 
diagnosis, should 
prompt a  
diagnosis of PID
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